Skip to content
Yog Pharma
Assessed against ICH, FDA and USP–NF

An API is only as good as the file behind it. This is how we choose sources, what we check, and what your QA team receives.

14

documents in a full qualification file

  • CoA
  • SDS
  • DMF letter of authorization
  • GMP certificate
  • Nitrosamine risk assessment
  • Quality agreement

We start with the regulatory record, not the price. Before a manufacturing site supplies a Yog Pharma customer, we review:

  • GMP status of the manufacturing site, and which authority inspected it
  • FDA inspection history, including Form 483 observations, warning letters and import alerts
  • Whether a Type II US DMF is filed, and whether it has passed FDA's completeness assessment
  • The specification, compared against the current USP or Ph. Eur. monograph
  • Certificates of analysis from at least three recent batches, for consistency
  • Change control, deviation and complaint procedures

A site that fails any of these checks is not offered for US supply, however competitive its price. Where a molecule matters to a customer’s line, we work to qualify more than one source, so a single plant shutdown doesn’t interrupt supply.

A full qualification file holds 14 documents. Three arrive with the first quote, so your team can judge the source before anyone discusses price. The rest follow during qualification, and the quality agreement is signed before the first commercial batch.

With the quote

3 documents
  • Specification

    The tests, methods and limits the material is released against.

  • Certificate of analysis

    Results for a recent batch, signed by the manufacturer's quality unit. One follows with every batch you buy.

  • Regulatory status summary

    The US DMF number and its completeness assessment status, any CEP, and the site's GMP standing.

During qualification

10 documents
  • Method of analysis

    So your lab can reproduce release testing for incoming inspection.

  • Safety data sheet

    Handling, storage and hazard information under OSHA's Hazard Communication Standard.

  • DMF letter of authorization

    Lets FDA review the confidential DMF on behalf of your ANDA, where a DMF is filed.

  • GMP certificate and inspection evidence

    Proof of the site's compliance status from the inspecting authority.

  • Route of synthesis outline

    Starting materials, intermediates and solvents, at the level the manufacturer discloses.

  • Residual solvents statement

    Solvents used in the process and their limits, per ICH Q3C.

  • Elemental impurities assessment

    Risk assessment for metal catalysts and other elemental impurities, per ICH Q3D.

  • Nitrosamine risk assessment

    The manufacturer's evaluation under FDA guidance, with confirmatory test results where risk is identified.

  • TSE/BSE statement

    Confirms whether any material of animal origin is used in manufacture.

  • Stability summary

    Retest period and storage conditions, supported by stability data.

Before commercial supply

1 document
  • Quality agreement

    Change notification, complaint handling and recall support, signed before the first commercial batch ships.

Change control

Manufacturers change sites, synthetic routes, solvents and their own suppliers. Any of these can affect your filing, and some need a supplement to your ANDA before you can use the material.

We agree notification terms in the quality agreement before commercial supply starts. When a source notifies a change, we pass it to you as soon as we receive it, with the supporting data, so your regulatory team can assess the filing impact before any changed batch ships.

Audits

If your QA team wants to audit the manufacturing site, we arrange it, attend if you want us there, and follow up on observations until they are closed. Where the manufacturer permits, we can share recent third-party audit reports for a desk-based assessment.

Complaints and recalls

Every complaint is logged, investigated with the manufacturer and closed in writing, with the root cause and corrective action. If a batch is recalled, we notify affected customers immediately and trace material by batch number to your receiving dock.

Sources, specifications and documents are reviewed against these guidelines and regulations.

Qualifying a new source?

Tell us the API and your filing requirements. We’ll send the specification, a recent CoA and the regulatory status with the quote. See twelve questions to ask an API supplier for what to look for.

Request documents